Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.
Raman CS, Li H, Martásek P, Babu BR, Griffith OW, Masters BS, Poulos TL.
Raman CS, et al. Among authors: martasek p.
J Biol Chem. 2001 Jul 13;276(28):26486-91. doi: 10.1074/jbc.M102255200. Epub 2001 Apr 30.
J Biol Chem. 2001.
PMID: 11331290
Free article.
Isothioureas are potent NOS inhibitors, and the structures of the endothelial NOS heme domain complexed with isothioureas bearing small S-alkyl substituents have been determined (Li, H., Raman, C.S., Martasek, P., Kral, V., Masters, B.S.S., and Poulos, T.L. (2000) J …
Isothioureas are potent NOS inhibitors, and the structures of the endothelial NOS heme domain complexed with isothioureas bearing small S-al …